ATI LPN
ATI Mental Health Practice A 2023
1. Which medication is commonly used to treat both major depressive disorder and neuropathic pain?
- A. Gabapentin
- B. Duloxetine
- C. Amitriptyline
- D. Tramadol
Correct answer: B
Rationale: Duloxetine, also known as Cymbalta, is a medication commonly used to treat both major depressive disorder and neuropathic pain. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that helps alleviate symptoms associated with these conditions. Gabapentin is primarily used for neuropathic pain, Amitriptyline is commonly used as an antidepressant, and Tramadol is an opioid analgesic often used for pain relief but not typically indicated for major depressive disorder.
2. What is the primary goal of exposure therapy for a patient with specific phobia?
- A. To eliminate the phobic response completely
- B. To increase the patient's exposure to the feared object
- C. To help the patient confront and reduce their fear gradually
- D. To provide immediate relief from anxiety symptoms
Correct answer: C
Rationale: The primary goal of exposure therapy for a patient with a specific phobia is to help them confront their fear gradually, leading to a reduction in their fear response over time. This gradual exposure helps the individual learn to manage and cope with their phobia, ultimately reducing the intensity of their fear reactions. Choice A is incorrect because while the goal is to reduce the fear response, complete elimination may not always be feasible. Choice B is incorrect as the focus is not solely on increasing exposure but on gradual confrontation. Choice D is incorrect as the therapy aims for long-term reduction rather than immediate relief.
3. Which assessment question, when asked by the nurse, demonstrates an understanding of comorbid mental health conditions associated with major depressive disorder?
- A. Do rules apply to you?
- B. What do you do to manage anxiety?
- C. Do you have a history of disordered eating?
- D. Do you think that you drink too much?
Correct answer: B
Rationale: The correct answer is B. Inquiring about anxiety management demonstrates an understanding of the common comorbid condition of anxiety often seen alongside major depressive disorder. Anxiety and depression frequently coexist, and addressing anxiety management can provide insights into the patient's overall mental health status. Choices A, C, and D are incorrect because they do not directly address comorbid mental health conditions associated with major depressive disorder.
4. Which statement by a patient indicates an understanding of cognitive-behavioral therapy (CBT)?
- A. CBT will help me understand and change my thought patterns.
- B. CBT focuses on resolving past trauma.
- C. CBT will help me avoid my problems.
- D. CBT involves taking medication to manage symptoms.
Correct answer: A
Rationale: The correct answer is A. Cognitive-behavioral therapy (CBT) is a type of psychotherapy that focuses on helping patients understand and change their thought patterns to improve their mental health. This therapy aims to identify and modify negative or harmful thoughts and behaviors. Option A correctly reflects this fundamental concept of CBT, emphasizing the role of thought patterns in mental health improvement. Choices B and C are incorrect because CBT does not primarily focus on resolving past trauma or avoiding problems; instead, it concentrates on changing cognitive patterns. Choice D is also inaccurate as CBT does not involve medication management but rather focuses on cognitive and behavioral interventions.
5. A patient with generalized anxiety disorder (GAD) is prescribed sertraline. What is a common side effect the nurse should monitor for?
- A. Dry mouth
- B. Weight gain
- C. Insomnia
- D. Nausea
Correct answer: D
Rationale: Nausea is a common side effect associated with sertraline, a medication commonly used in the treatment of generalized anxiety disorder (GAD). It is essential for the nurse to monitor for nausea as it can impact the patient's adherence to the medication regimen. Educating the patient about this potential side effect and advising ways to manage it can enhance treatment compliance and overall therapeutic outcomes.
Similar Questions
Access More Features
ATI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access